Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Q. Zhou

P3.01-113 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

Journal of Thoracic Oncology

English

P084 Musashi-2 Expression Is an Prognostic Factor for Postoperative Survival in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.12-11 a Prognostic Model Integrating Immunohistochemistry Markers for Extensive-Disease Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.01-96 Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy

Journal of Thoracic Oncology

English

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

Journal of Thoracic Oncology

English

P2.04-30 PD-1/PD-L1 Inhibition Might Be an Option for the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma

Journal of Thoracic Oncology

English

P051 a Novel Model for Estimating Survival in Lung Cancer Patients With Leptomeningeal Metastasis

Journal of Thoracic Oncology

English

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

Journal of Thoracic Oncology

English

P2.01-122 Individual Precision Surgery for Locally Advanced Non-Small Cell Lung Cancer Based on Molecular Staging and Typing : The Chinese Experience.

Journal of Thoracic Oncology

English

P039 Clinical Characteristics and Survival of Patients With Lymphoepithelioma-Like Carcinoma in Lung and Bronchus and Other Sites

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Q. Zhou

P3.01-113 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

P084 Musashi-2 Expression Is an Prognostic Factor for Postoperative Survival in Patients With Non-Small Cell Lung Cancer

P2.12-11 a Prognostic Model Integrating Immunohistochemistry Markers for Extensive-Disease Small-Cell Lung Cancer

P1.01-96 Concurrent ALK/EGFR Alterations in Chinese Lung Cancers: Frequency, Clinical Features, and Differential Response to Therapy

MA02.06 a Randomized, Double-Blind, Placebo-Controlled Trial of Chemotherapy Combined With Yangzheng Xiaoji in Advanced NSCLC

P2.04-30 PD-1/PD-L1 Inhibition Might Be an Option for the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma

P051 a Novel Model for Estimating Survival in Lung Cancer Patients With Leptomeningeal Metastasis

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

P2.01-122 Individual Precision Surgery for Locally Advanced Non-Small Cell Lung Cancer Based on Molecular Staging and Typing : The Chinese Experience.

P039 Clinical Characteristics and Survival of Patients With Lymphoepithelioma-Like Carcinoma in Lung and Bronchus and Other Sites